FDA banned it in late 2023 "Category 2: Substance with Safety Concerns" Why the FDA banned it: Potential immune reactions (immunogenicity) Manufacturing impurities in compounded versions Complete lack of human safety data Risk of contamination Legal status: NOT FDA-approved Illegal to compound in pharmacies Banned by WADA for athletes Possession not illegal (it's not a DEA scheduled substance) Sold online as "research chemical" 2
Gounder and his colleagues published results from a large NCI-funded clinical trial showing that the drug sorafenib (Nexavar), a targeted therapy approved for the treatment of advanced kidney, liver, and thyroid cancer, halted the growth of desmoid tumors
These findings support BPC-157 as a versatile research compound for studying biological repair signaling, but they do not establish approved therapeutic use
BPC-157 has been shown to: Reduce systemic inflammation Lower oxidative stress Improve mobility & joint function By addressing the root cause instead of just masking symptoms, BPC-157 helps you stay active, pain-free, and performing at your best
Furthermore, the disruption of these intracellular epigenetic networks may explain individual pain perception and diseases associated with persistent hyperalgesic states
Unit variable data (per pair of shoes) Selling price Cost of shoes Sales commissions Variable cost per unit Annual fixed costs Rent Salaries, $96,000 + $19,190 Advertising Depreciation Other fixed costs Total fixed costs $ 40.00 29.00 0 29.00 $ $ 25,000 115,190 35,000 6,000 9,000 $ 190,190 CMU, $40 $29 a
